Vitamin C (Ascorbic Acid)
SupplementThe moderate positive gap arises because medical evidence for cold duration reduction and scurvy prevention is strong [s2, s6], while community users partly harbor exaggerated expectations regarding high-dose applications that are not clinically substantiated [c1, c2]. Community enthusiasm is genuine but extends beyond what is scientifically established.
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Vitamin C is biochemically essential for collagen synthesis and scurvy prevention — that's beyond debate. For colds, Cochrane data shows a moderate reduction in duration (~9%) but no meaningful drop in incidence in the general population. Megadose protocols (5–20 g/day) lack robust RCT support, and above 1,000 mg, GI side effects and kidney stone risk in susceptible individuals increase noticeably. A daily dose of 200–500 mg hits the sweet spot between benefit and safety.
Description
Water-soluble essential vitamin with antioxidant activity, roles in collagen synthesis, immune function, and iron absorption; well-established for reducing common cold duration [s1, s2].
Vitamin C (L-ascorbic acid) is a water-soluble essential micronutrient that the human organism cannot synthesize endogenously and must obtain exclusively through dietary intake [s1]. It acts as a potent antioxidant in aqueous body fluids (plasma, cytoplasm, extracellular fluid), scavenging free radicals and regenerating other antioxidants such as vitamin E [s1, s3]. As an essential cofactor for prolyl and lysyl hydroxylases, vitamin C is indispensable for stable collagen cross-linking; deficiency leads to classic scurvy [s1, s6]. Additionally, it supports carnitine biosynthesis, catecholamine metabolism, and non-heme iron absorption in the small intestine [s1]. Absorption occurs via saturable sodium-dependent transporters (SVCT1 in the small intestine, SVCT2 in tissues): at single oral doses up to 200 mg, approximately 70–90% is absorbed; at 1,000 mg, the absorption rate drops below 50%, and excess vitamin C is renally excreted [s5, s7]. Liposomal formulations demonstrate an approximately 1.4-fold higher plasma AUC compared to non-liposomal forms in direct comparison [s8]. For prevention of the common cold in the general population, regular supplementation (≥0.2 g/day) shows no significant reduction in cold incidence (RR 0.97), but does produce a statistically significant reduction in cold duration of approximately 9.4% [s2]. A more pronounced protective effect has been observed in individuals under extreme physical stress (soldiers, marathon runners) [s2]. Evidence for cancer and cardiovascular prevention through supplementation is weak to absent; meta-analyses show no consistent clinical effects [s4, s9]. High-dose intravenous application in cancer patients is being investigated in Phase II studies; robust Phase III evidence is lacking [s4]. The EU recommended reference value (NRV) is 80 mg/day; the current adequate intake estimate (AI) according to E...
Legal Status (DE)
Vitamin C (ascorbic acid and its salts) is fully marketable as an over-the-counter food supplement (NEM) in Germany, Austria, and Switzerland. The BfR recommends a maximum daily amount of 1,000 mg elemental vitamin C in food supplements [s11]. High-dose intravenous applications are considered medicinal use and are not permitted outside medical supervision. No uniformly legislated maximum levels currently exist within the EU [s12].
Mechanism of Action
Vitamin C acts through several well-characterized biochemical mechanisms [s1]: 1. Antioxidant function: Ascorbate donates electrons to free radicals (reactive oxygen species, ROS) in aqueous compartments, being oxidized to the stable ascorbyl radical. Vitamin E radicals are regenerated by ascorbate (vitamin C/E synergy) [s3]. 2. Collagen biosynthesis: Vitamin C is an indispensable cofactor of prolyl-4-hydroxylase and lysyl hydroxylase. These enzymes hydroxylate proline and lysine residues in pro-collagen, enabling stable triple helix formation and cross-linking of collagen fibrils. Without adequate vitamin C, this structure collapses → scurvy [s1, s6]. 3. Immunomodulation: Vitamin C accumulates in immune cells (neutrophils, lymphocytes) at concentrations 10–100× above plasma levels. It supports chemotactic migration, phagocytosis, and oxidative burst of neutrophils, as well as differentiation and proliferation of T and B lymphocytes [s1]. 4. Catecholamine and carnitine synthesis: Vitamin C is a cofactor of dopamine-β-hydroxylase (noradrenaline synthesis) and two enzymes of carnitine biosynthesis (ε-N-trimethyllysine hydroxylase, γ-butyrobetaine hydroxylase) [s1]. 5. Iron absorption: In the small intestine, ascorbate reduces Fe³⁺ to Fe²⁺, which is more efficiently absorbed via DMT1. This is particularly relevant for plant-based (non-heme) iron intake [s1]. 6. Bioavailability and saturation: Absorption is regulated by SVCT1 (small intestine) and SVCT2 (tissues). The transporters are saturable; at high single doses (>500 mg), fractional absorption decreases markedly [s5, s7].
Dosing
Bedarfsdeckung und Skorbut-Prävention (Erwachsene)
- Dose
- 75–90 mg/day (women 75 mg, men 90 mg)
- Frequency
- 1× täglich
- Route
- oral
- Duration
- fortlaufend
- Timing
- With meals
- With food
- empfohlen
Erkältungsdauer-Reduktion (präventive Supplementierung)
- Dose
- 200–1,000 mg/day
- Frequency
- 1–2× täglich
- Route
- oral
- Duration
- fortlaufend
- Timing
- Any time, preferably with a meal
- With food
- optional
Eisenresorption verbessern (pflanzliche Kost)
- Dose
- 100–200 mg simultaneously with an iron-rich meal
- Frequency
- zu eisenhaltigen Mahlzeiten
- Route
- oral
- Duration
- situationsabhängig
- Timing
- Simultaneously with the meal
- With food
- empfohlen
Kollagenunterstützung / Hautpflege (oral)
- Dose
- 500–1,000 mg/day
- Frequency
- 1× täglich
- Route
- oral
- Duration
- mindestens 8 Wochen
- Timing
- In the morning or at midday
- With food
- empfohlen
The BfR recommends a maximum daily amount of 1,000 mg vitamin C in food supplements for adults [s11]. The EFSA has not established a formal UL but cites 1,000 mg/day as safe for the general population [s10]. Intake >1,000 mg/day increases the risk of gastrointestinal complaints and, in predisposed males, calcium oxalate kidney stones [s13, s14].
Liposomal vitamin C shows an approximately 1.4-fold higher plasma AUC than standard ascorbic acid; clinical superiority for endpoints has not yet been demonstrated [s8]. At single doses >500 mg, fractional absorption rate decreases substantially [s5].
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Gastrointestinale Beschwerden (Durchfall, Übelkeit, Magenkrämpfe) Osmotically driven effect of unabsorbed ascorbic acid in the colon. Typically occurs at doses >1,000 mg/day and is dose-dependently reversible [s10, s11]. | häufig | leicht |
| Erhöhte Oxalatausscheidung im Urin Vitamin C is partially metabolized to oxalate; at 1–2 g/day, urinary oxalate excretion increases by 20–60%. Caution is warranted in individuals with a predisposition to calcium oxalate kidney stones [s13]. | gelegentlich | leicht |
| Nierensteinbildung (Calciumoxalat) bei Hochdosis Swedish cohort study (45,619 men, 14-year follow-up): >7 vitamin C tablets/week associated with 2.23-fold increased kidney stone risk. Particularly relevant in men with predisposition [s14]. | selten | moderat |
| Akutes Nierenversagen (Oxalatnephropathie) bei intravenöser Hochdosis Documented in case reports in patients with pre-existing renal impairment and very high i.v. dosing; oxalate crystal deposition in tubular epithelium [s15]. | selten | schwer |
| Prooxidativer Effekt bei sehr hohen Konzentrationen In the presence of free transition metal ions (Fe²⁺, Cu²⁺), ascorbate can generate reactive oxygen species (Fenton reaction). Clinical relevance at standard oral doses not established [s1]. | theoretisch | moderat |
| Interaktion mit Chemotherapie (antioxidativer Schutz von Tumorzellen) High-dose antioxidants could theoretically reduce the cytotoxic efficacy of certain chemotherapeutic agents. Clinical evidence is contradictory; medical consultation is mandatory [s4]. | theoretisch | moderat |
Contraindications
Vitamin C substantially increases iron absorption. In iron storage disorders, this can lead to dangerous iron accumulation and organ damage [s1].
High-dose vitamin C (particularly i.v.) can trigger hemolytic anemia in G6PD deficiency, as affected erythrocytes cannot compensate for oxidative stress [s1].
Increased oxalate excretion with high-dose vitamin C raises the recurrence risk for calcium oxalate stones. Supplementation >500 mg/day only after medical assessment [s13, s14].
Impaired clearance of oxalate and ascorbate; risk of oxalate nephropathy and further deterioration of renal function [s15].
Possible attenuation of chemotherapy efficacy due to antioxidant properties of vitamin C. Consultation with the treating oncologist required [s4].
Interactions
Synergistic
Ascorbate regenerates the oxidized tocopheryl radical back to vitamin E; synergistic antioxidant protection, particularly against photooxidative stress [s3].
Vitamin C reduces Fe³⁺ to Fe²⁺ in the small intestine and significantly increases absorption of non-heme iron compounds. Beneficial in iron-deficiency anemia with plant-based diets [s1].
Vitamin C enhances absorption of iron bisglycinate in the small intestine via reduction of Fe³⁺ to Fe²⁺ and chelation. This combination improves bioavailability particularly with plant-based diets and iron-deficiency anemia.
Vitamin C and CoQ10 act synergistically as antioxidants; vitamin C can regenerate oxidized CoQ10 and vice versa. This mutual regeneration enhances the oxidative protection of both compounds.
Alpha-lipoic acid can regenerate spent (oxidized) vitamin C to its active form, thereby increasing intracellular availability. This combination is considered one of the most potent natural antioxidant networks.
Caution
High-dose vitamin C (>1 g/day) can affect INR and may attenuate or potentiate anticoagulant activity. Close INR monitoring recommended [s16].
Vitamin C may reduce plasma levels of indinavir. A minimum interval of 2 hours between administrations is recommended [s16].
Possible impairment of antibiotic absorption; a minimum separation interval of 2 hours is recommended [s16].
High-dose antioxidants may theoretically reduce ROS-dependent cytotoxicity. Contraindicated without oncological consultation [s4].
When applied topically concomitantly, L-ascorbic acid may compromise GHK-Cu stability due to its low pH, reducing the efficacy of both compounds. A minimum interval of 30 minutes between applications is recommended.
Studies
Tier A — High Evidence
Outcome: Severity of cold symptoms (severe vs. mild symptoms); comparison of the relative effect of vitamin C on severe versus mild symptoms.
Effect Size: Vitamin C reduced severe cold symptoms more than mild symptoms; the meta-analysis confirms a dose-dependent effect on symptom severity. Exact pooled effect size (RR/MD with CI) is available in the full text of the study (doi:10.1186/s12889-023-17229-8).
Tier B — Moderate Evidence
Outcome: Incidence of kidney stones in men taking ascorbic acid supplements compared to non-users.
Effect Size: Ascorbic acid supplement intake was associated with a significantly increased risk of first-time kidney stones (hazard ratio elevated; details in full text). Study previously incorrectly assigned to s8.
Community Evidence
Top reported benefits
- Subjectively shorter cold duration at 500–1,000 mg/day
- General well-being and 'energy boost' at higher doses
- Improved skin condition with long-term use
- Reduction of brain fog (anecdotal at high doses)
- Faster recovery from infections
Top reported issues
- Gastric problems and diarrhea at doses >1,000 mg
- No noticeable effect in many users at standard dose
- Uncertainty regarding optimal dosing and benefit of megadoses
A relevant portion of the community takes megadoses (5–20 g/day) without medical supervision [c1, c2]. Skeptical voices point to the absence of RCT evidence for high-dose protocols and emphasize that zinc has better-established immune effects [c2]. German forum users occasionally report kidney stone concerns and reference reports from the Deutsches Ärzteblatt [c3].
Scientific Sources
- Vitamin C (Ascorbic Acid) - StatPearls
Maxfield L, Crane JS, et al. (2023). StatPearls Publishing / NCBI BookshelfBLink - EFSA publishes reference values for intake of vitamin C and manganese
EFSA NDA Panel (2013). EFSA JournalALink - Höchstmengenvorschläge für Vitamin C in Lebensmitteln inklusive Nahrungsergänzungsmitteln
Bundesinstitut für Risikobewertung (BfR) (2024). BfR Stellungnahme 006/2024ALink - Höchstmengen für Vitamine und Mineralstoffe in der EU
Verbraucherzentrale Deutschland (2024). Verbraucherzentrale.deBLink - High-dose vitamin C linked to kidney stones in men
Harvard Health Publishing (2013). Harvard Health BlogCLink - Nierensteine durch Vitamin C – Deutsches Ärzteblatt
Deutsches Ärzteblatt Redaktion (2013). Deutsches ÄrzteblattBLink - Oxalate Nephropathy Caused by Excessive Vitamin C Administration in 2 Patients With COVID-19
Batlle D, Soler MJ, Sparks MA, et al. (2020). American Journal of Kidney Diseases / PMCCLink - 7 Ways Vitamin C Interacts with Your Meds, According to Health Experts
EatingWell Editorial Staff (2024). EatingWell / Dotdash MeredithCLink - Vitamin C reduces the severity of common colds: a meta-analysis
Hemilä H (2023). BMC Public Health (PMC)ALink - Ascorbic acid supplements and kidney stone incidence among men: a prospective study
Thomas LDK, Elinder CG, Tiselius HG, Wolk A, Akesson A (2013). JAMA Internal MedicineCPMID:23381591DOI - Vitamin C for preventing and treating the common cold
Hemilä H, Chalker E (2013). Cochrane Database of Systematic ReviewsAPMID:23440782DOI - Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions
Carr AC, Cook J, et al. (2025). Basic & Clinical Pharmacology & Toxicology (Wiley)ADOI - Efficacy of Vitamin C Supplements in Prevention of Cancer: A Meta-Analysis of Randomized Controlled Trials
Myung SK, Kim Y, Ju W, et al. (2015). Korean Journal of Family Medicine / PMCALink - Ascorbinsäure – Wikipedia (Bioverfügbarkeit, Transporter, Dosisabhängigkeit)
Wikipedia-Autoren (2024). Wikipedia (Deutsch)DLink - New analysis of landmark scurvy study leads to update on vitamin C needs
University of Washington News (2021). UW NewsBLink - Stabilität, Bioverfügbarkeit & Formulierung – worauf es bei Vitamin-C-Präparaten ankommt
bluevitality.de Redaktion (2024). bluevitality.deDLink - Total, Dietary, and Supplemental Vitamin C Intake and Risk of Incident Kidney Stones
Ferraro PM, Curhan GC, Gambaro G, et al. (2016). American Journal of Kidney DiseasesBLink - Vitamin C supplementation for the primary prevention of cardiovascular disease
Ashor AW, Lara J, Mathers JC, et al. (2019). Cochrane Database / PMCALink
Community Sources
Storage
Unopened
Store in a dry, cool place (15–25 °C), protected from direct light.
Opened
Keep container tightly closed; ascorbic acid oxidizes upon exposure to light, heat, and oxygen. Powder forms should be stored with particular protection from moisture after opening.
Notes
Liposomal formulations may require refrigeration (2–8 °C) — follow manufacturer instructions. Effervescent tablets should be consumed immediately after dissolution; dissolved ascorbic acid is unstable [s5].